Alrefaei Abdulmajeed F, Elbeeh Mohamed E
Department of Biology/Genetic and Molecular Biology Central Laboratory (GMCL), Jamoum University College, Umm Al-Qura University, Makkah 2203, Saudi Arabia.
Department of Biology, Jamoum University College, Umm Al-Qura University, Makkah 21955, Saudi Arabia.
Biology (Basel). 2025 Mar 18;14(3):307. doi: 10.3390/biology14030307.
Diabetes mellitus is a chronic metabolic disorder that often leads to hepatic complications, including oxidative stress, inflammation, and structural damage, highlighting the need for effective hepatoprotective agents. (licorice), known for its bioactive compounds with medicinal properties, has gained attention as a potential therapeutic option. This study investigated its hepatoprotective effects in a diabetic rat model. Diabetes was induced using streptozotocin, and animals were divided into four groups: a healthy control, a non-diabetic group treated with extract, an untreated diabetic group, and a diabetic group receiving daily doses of the extract. Liver function was assessed through serum enzyme levels (ALT, AST, and ALP), while oxidative stress markers, including malondialdehyde (MDA) and glutathione (GSH), were analyzed. Histological examination was conducted to evaluate inflammation, fibrosis, and fatty degeneration. Treatment with significantly improved liver function in diabetic rats, as evidenced by lower ALT, AST, and ALP levels compared to untreated diabetic rats ( < 0.05), suggesting hepatocyte protection through its antioxidant and anti-inflammatory properties. Favorable changes in oxidative stress markers were observed, with lower MDA levels indicating reduced lipid peroxidation and higher GSH activity reflecting enhanced antioxidant defense. Histological analysis confirmed these protective effects, showing reduced inflammation, diminished fatty degeneration, and overall structural improvements. These findings highlight the hepatoprotective potential of , suggesting it may be a promising therapeutic agent for managing hepatic complications associated with diabetes mellitus, though further research with larger sample sizes and mechanistic studies is needed for confirmation.
糖尿病是一种慢性代谢紊乱疾病,常导致肝脏并发症,包括氧化应激、炎症和结构损伤,这凸显了对有效肝脏保护剂的需求。甘草因其具有药用特性的生物活性化合物而闻名,作为一种潜在的治疗选择受到了关注。本研究调查了其在糖尿病大鼠模型中的肝脏保护作用。使用链脲佐菌素诱导糖尿病,将动物分为四组:健康对照组、接受提取物治疗的非糖尿病组、未治疗的糖尿病组和每日接受提取物剂量的糖尿病组。通过血清酶水平(ALT、AST和ALP)评估肝功能,同时分析包括丙二醛(MDA)和谷胱甘肽(GSH)在内的氧化应激标志物。进行组织学检查以评估炎症、纤维化和脂肪变性。与未治疗的糖尿病大鼠相比,提取物治疗显著改善了糖尿病大鼠的肝功能,ALT、AST和ALP水平较低证明了这一点(P<0.05),表明通过其抗氧化和抗炎特性对肝细胞有保护作用。观察到氧化应激标志物有有利变化,较低的MDA水平表明脂质过氧化减少,较高的GSH活性反映抗氧化防御增强。组织学分析证实了这些保护作用,显示炎症减轻、脂肪变性减少以及整体结构改善。这些发现突出了甘草的肝脏保护潜力,表明它可能是治疗与糖尿病相关肝脏并发症的一种有前景的治疗剂,不过需要进一步进行更大样本量的研究和机制研究来证实。